Skip to content

REMEDENT, INC.: 10-Q filed 2015-11-16

What REMEDENT, INC. reported in its quarterly report filed 2015-11-16 (fiscal Q2 2016): 34 published measures, 102 facts as tagged in accession 0001144204-15-065909.

This filing

Form
10-Q (quarterly report)
Filed
2015-11-16
Fiscal period
fiscal Q2 2016
Accession
0001144204-15-065909 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All REMEDENT, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2015-09-305,694,095USD
At 2015-03-315,544,796USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2015-09-302,300,274USD
At 2015-03-312,032,314USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2015-09-30147,943USD
At 2015-03-31399,149USD
At 2014-09-30121,198USD
At 2014-03-31775,286USD

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2015-09-30-20,723,617USD
At 2015-03-31-20,974,904USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2015-07-01 to 2015-09-3019,995,969shares92
2015-04-01 to 2015-09-3019,995,969shares183
2014-07-01 to 2014-09-3019,995,969shares92
2014-04-01 to 2014-09-3019,995,969shares183

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2015-07-01 to 2015-09-3019,995,969shares92
2015-04-01 to 2015-09-3019,995,969shares183
2014-07-01 to 2014-09-3019,995,969shares92
2014-04-01 to 2014-09-3019,995,969shares183

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2015-07-01 to 2015-09-300USD/shares92
2015-04-01 to 2015-09-300.01USD/shares183
2014-07-01 to 2014-09-300USD/shares92
2014-04-01 to 2014-09-300.01USD/shares183

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2015-07-01 to 2015-09-300USD/shares92
2015-04-01 to 2015-09-300.01USD/shares183
2014-07-01 to 2014-09-300USD/shares92
2014-04-01 to 2014-09-300.01USD/shares183

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2015-07-01 to 2015-09-3025,000USD92
2015-04-01 to 2015-09-30103,692USD183
2014-07-01 to 2014-09-300USD92
2014-04-01 to 2014-09-300USD183

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2015-09-30438,046USD
At 2015-03-31435,268USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2015-07-01 to 2015-09-3047,983USD92
2015-04-01 to 2015-09-30254,665USD183
2014-07-01 to 2014-09-3010,938USD92
2014-04-01 to 2014-09-305,665USD183

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2015-09-302,910,339USD
At 2015-03-312,906,788USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2015-07-01 to 2015-09-3015,785USD92
2015-04-01 to 2015-09-3032,465USD183
2014-07-01 to 2014-09-3016,123USD92
2014-04-01 to 2014-09-3035,526USD183

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2015-09-303,300,649USD
At 2015-03-313,441,735USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2015-09-30699,364USD
At 2015-03-31846,773USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2015-09-301,058,054USD
At 2015-03-31847,144USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2015-07-01 to 2015-09-30443,970USD92
2015-04-01 to 2015-09-30798,774USD183
2014-07-01 to 2014-09-30604,000USD92
2014-04-01 to 2014-09-301,208,038USD183

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2015-09-30386,822USD
At 2015-03-31414,034USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2015-07-01 to 2015-09-30491,953USD92
2015-04-01 to 2015-09-301,053,439USD183
2014-07-01 to 2014-09-30614,938USD92
2014-04-01 to 2014-09-301,213,703USD183

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2015-07-01 to 2015-09-301,635USD92
2015-04-01 to 2015-09-305,230USD183
2014-07-01 to 2014-09-3025,448USD92
2014-04-01 to 2014-09-3039,169USD183

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2015-09-3019,995,969shares
At 2015-03-3119,995,969shares

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2015-09-302,393,446USD
At 2015-03-312,103,061USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2015-09-302,478,106USD
At 2015-03-312,414,252USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2015-09-302,040,060USD
At 2015-03-311,978,984USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2015-09-30294,314USD
At 2015-03-31334,748USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2015-07-01 to 2015-09-3079,983USD92
2015-04-01 to 2015-09-30377,403USD183
2014-07-01 to 2014-09-3083,032USD92
2014-04-01 to 2014-09-30155,081USD183

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2015-07-01 to 2015-09-30-305USD92
2015-04-01 to 2015-09-30-22,424USD183
2014-07-01 to 2014-09-302,163USD92
2014-04-01 to 2014-09-30-12,246USD183

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2015-07-01 to 2015-09-3082,432USD92
2015-04-01 to 2015-09-30267,960USD183
2014-07-01 to 2014-09-3015,631USD92
2014-04-01 to 2014-09-3062,190USD183

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2015-07-01 to 2015-09-3054,678USD92
2015-04-01 to 2015-09-30251,287USD183
2014-07-01 to 2014-09-3085,195USD92
2014-04-01 to 2014-09-30142,835USD183

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2015-07-01 to 2015-09-30310,260USD92
2015-04-01 to 2015-09-30531,824USD183
2014-07-01 to 2014-09-30312,168USD92
2014-04-01 to 2014-09-30617,660USD183

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2015-07-01 to 2015-09-3032,000USD92
2015-04-01 to 2015-09-30122,738USD183
2014-07-01 to 2014-09-3072,094USD92
2014-04-01 to 2014-09-30149,416USD183

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2015-04-01 to 2015-09-30210,910USD183
2014-04-01 to 2014-09-30192,736USD183

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2015-04-01 to 2015-09-30-27,212USD183
2014-04-01 to 2014-09-30-59,785USD183

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2015-04-01 to 2015-09-30-138,446USD183
2014-04-01 to 2014-09-30179,037USD183

Inspect the source

Entity
REMEDENT, INC. / CIK 0001078037
Captured
SEC response SHA-256
45fceec6324be1015fe5b91364230644b1829b27482c22b4c8e0a8b6c3dc5393

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001078037.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))